Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · IEX Real-Time Price · USD
8.00
-0.12 (-1.48%)
At close: Jul 19, 2024, 12:00 AM
7.89
-0.11 (-1.38%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Fulcrum Therapeutics Employees
Fulcrum Therapeutics had 76 employees as of December 31, 2023. The number of employees decreased by 13 or -14.61% compared to the previous year.
Employees
76
Change (1Y)
-13
Growth (1Y)
-14.61%
Revenue / Employee
$33,026
Profits / Employee
-$1,308,237
Market Cap
497.23M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Sharecare | 3,352 |
GRAIL, LLC | 1,360 |
Treace Medical Concepts | 516 |
Jin Medical International | 245 |
COMPASS Pathways | 186 |
Heron Therapeutics | 126 |
Y-mAbs Therapeutics | 100 |
Oculis Holding AG | 36 |
FULC News
- 6 days ago - Top 3 Health Care Stocks That Should Keep You Up At Night This Quarter - Benzinga
- 2 months ago - Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2024 - GlobeNewsWire
- 2 months ago - Fulcrum Therapeutics Enters into a Collaboration and License Agreement with Sanofi for the Development and Commercialization of Losmapimod in Facioscapulohumeral Muscular Dystrophy - GlobeNewsWire
- 2 months ago - Fulcrum Therapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Monday, May 13, 2024, at 8:00 a.m. ET - GlobeNewsWire
- 4 months ago - Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 months ago - Fulcrum Therapeutics Appoints Patrick Horn M.D., Ph.D., as Chief Medical Officer - GlobeNewsWire
- 4 months ago - Fulcrum Therapeutics to Participate at the Leerink Partners Global Biopharma Conference - GlobeNewsWire
- 5 months ago - Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2023 - GlobeNewsWire